- Home
- FBRT vs AURA Comparison
FBRT vs AURA Comparison
Compare FBRT & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | AURA |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.9M | 797.5M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FBRT | AURA |
|---|---|---|
| Price | $7.80 | $6.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $11.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.7M | 798.4K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $270,071,000.00 | N/A |
| Revenue This Year | $12.34 | N/A |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | $42.11 | ★ N/A |
| Revenue Growth | ★ 28.33 | N/A |
| 52 Week Low | $7.35 | $4.73 |
| 52 Week High | $11.53 | $9.54 |
Technical Indicators
Market Signals| Indicator | FBRT | AURA |
|---|---|---|
| Relative Strength Index (RSI) | 35.46 | 40.12 |
| Support Level | $7.35 | $6.65 |
| Resistance Level | $8.00 | $7.18 |
| Average True Range (ATR) | 0.21 | 0.34 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 0.48 | 5.11 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.